Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase

R. S. Stack, C. M. O'Connor, D. B. Mark, T. Hinohara, H. R. Phillips, M. M. Lee, N. M. Ramirez, W. G. O'Callaghan, C. A. Simonton, E. B. Carlson, K. G. Morris, V. S. Behar, Y. Kong, R. H. Peter, R. M. Califf

Research output: Contribution to journalArticle

102 Scopus citations

Abstract

Two hundred and sixteen patients with acute myocardial infarction were treated with immediate infusion of high-dose (1.5 million units) intravenous streptokinase followed by emergency coronary angioplasty. The infarct lesion was crossed and dilated in 99% and persistent coronary perfusion after the procedure was achieved in 90% (including 3% with significant residual stenosis). Total in-hospital mortality was 12%. Multivariable analysis showed a higher hospital mortality with cardiogenic shock (41% vs 5% without shock), older age, lower left ventricular ejection fraction, and female sex. Final patency of the infarct-related vessel was determined by follow-up in-hospital cardiac catheterization. Coronary reocclusion occurred in 11% (symptomatic in 7%, treated with emergency angioplasty or bypass surgery; silent in 4%, treated medically). Of the surviving patients with successful initial establishment of infarct vessel patency, 94% were discharged from the hospital with an open infarct artery or a bypass graft to the infarct vessel. There was significant improvement in both ejection fraction (44% to 49%; p < .0001) and regional wall motion in the infarct zone (- 3.0 SD to -2.4 SD; p < .0001) among patients with persistent coronary perfusion and insignificant residual stenosis at the time of the follow-up cardiac catheterization. Thus, a treatment strategy for acute myocardial infarction that includes immediate administration of streptokinase followed by emergency coronary angioplasty, and coronary bypass surgery when necessary, results in a high rate of early and sustained patency of the infarct-related vessel.

Original languageEnglish (US)
Pages (from-to)151-161
Number of pages11
JournalCirculation
Volume77
Issue number1
DOIs
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase'. Together they form a unique fingerprint.

  • Cite this

    Stack, R. S., O'Connor, C. M., Mark, D. B., Hinohara, T., Phillips, H. R., Lee, M. M., Ramirez, N. M., O'Callaghan, W. G., Simonton, C. A., Carlson, E. B., Morris, K. G., Behar, V. S., Kong, Y., Peter, R. H., & Califf, R. M. (1988). Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. Circulation, 77(1), 151-161. https://doi.org/10.1161/01.CIR.77.1.151